Today's Stock News: Latest Updates on Public Companies

Markets and capital moves

Lisata Therapeutics (LSTA) agreed to acquire Marea Therapeutics and arranged a $225 million concurrent private placement, a transformational financing that materially strengthens the balance sheet ahead of integration and clinical development.

Calidi Biotherapeutics (CLDI) priced a $1.2 million registered direct offering, a modest capital raise that reduces near-term funding pressure for its oncology programs.

Lexaria (LEXX) posted an update to its financial position, a liquidity note investors should weigh when assessing runway and commercialization timing.

AI, enterprise software and commercial scale

Datasea (DTSS) said its AI agent digital-marketing services moved into scaled commercial deployment with five agreements that represent up to US$89.4 million in potential annualized service volume, a big-canvas commercial validation for platform-driven digital services.

Fusemachines (FUSE) unveiled an AI Twin technology aimed at workplace automation, a product bet that could accelerate enterprise adoption if integration and ROI prove attractive.

Fabric.AI (FABC) appointed Haynes Boone as counsel to support joint intellectual property work with Kopin, a legal step that can smooth commercialization and protect shared tech assets as partners scale.

Amaze (AMZE) launched a new subscription model that management says will lift recurring revenue potential, a strategic pivot investors track when forecasting steady cash flows and churn dynamics.

AIAI Holdings (AIAI)'s Constellation Network launched Dôr Patient Journey with Proactive MD(R), expanding AI-driven care coordination—an example of how health-tech platforms are pushing for measurable clinical and operational value.

Defense, sensors and autonomy

MicroVision (MVIS) said its IRIS long‑range LiDAR was selected for advanced autonomous ground‑vehicle defense applications, a design win that can open follow-on qualification and production opportunities with prime contractors.

Silynxcom (SYNX) received two consecutive orders totaling about $400,000 from a leading global defense company, a near-term revenue bump that also signals product fit within established defense supply chains.

Innoviz Technologies (INVZ) — earlier recognized by the Israel Defense Forces' research directorate for its LiDAR — and MicroVision’s selection together underscore growing investor interest in perception sensors tailored for defense and autonomy programs.

Biotech, approvals and clinical progress

MIRA Pharmaceuticals (MIRA) advanced Ketamir‑2 into Phase 2a for chemotherapy‑induced peripheral neuropathy after FDA review, a clinical milestone that can increase partnering value if safety and early efficacy are confirmed.

Sol‑Gel Technologies (SLGL) announced last patient, last visit in its pivotal Phase 3 trial for SGT‑610 in Gorlin syndrome, clearing the way for data readouts that will drive regulatory and commercial planning.

Lisata Therapeutics (LSTA)'s acquisition of Marea and the concurrent financing (noted above) are material because they bulk up clinical assets and provide funding to accelerate trials and potential filings.

Energy, storage and infrastructure

INNIO (INIO) secured a 450 MW order tied to hyperscale data-center builds, a direct link between generator demand and cloud capital expenditure cycles.

NeoVolta (NEOV) signed a capacity reservation ahead of its Pendergrass facility opening, signaling strengthening battery-pack demand for EVs and storage deployments.

Quantum, satellites and advanced tech deployments

Telesat (TSAT) and Orange inaugurated Europe’s first Telesat Lightspeed gateway, a low‑latency LEO milestone that could expand enterprise and defense use cases for satellite broadband.

IonQ (IONQ) reported up to 14.6% acceleration on a computer‑aided engineering workload using quantum resources, an early performance claim that investors will watch for reproducibility and route to commercial advantage.

Government, federal orders and GSA-type wins

Cemtrex / Vicon (CETX) secured about $2.8 million in orders from a U.S. federal agency, reinforcing recurring government revenue potential for integrated-vision providers.

Primech Holdings (PMEC) won a US$5.78 million three‑year facility services contract, a sizeable commercial agreement that supports multi-year revenue visibility.

Corporate boards, leadership and index moves

Pagaya (PGY) added payments veteran Jason Gardner to its board, strengthening fintech expertise as the company hones monetization strategies.

Boost Run (BRUN) received preliminary inclusion in the Russell 2000/3000, a potential catalyst for passive inflows when finalized.

Other notable commercial wins

• Nuwellis (NUWE) reported 31 Aquadex SmartFlow consoles sold YTD, expanding recurring revenue potential in hospital fluid management.
• Faraday Future (FFAI) reported balance-sheet improvements and about 552 EAI robots sold with positive product gross margin, data that matters for liquidity and product‑market fit.
• Precision Optics (POCI) received an initial engineering order from a satellite optical-communications customer, validating readiness for LEO/GEO optical links.